Treatment for Migraine and Mood (TEAM-M): A Pilot Trial of Mindfulness-based Training Program
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Depressive Symptoms
-
Age: Between 18 years - 100 years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Currently meets ICHD-3 criteria for migraine using the Structured Diagnostic Interview for Headache
- Self-reported 4-14 headache days per month, with at least one attack meeting migraine criteria
- Score between 5-14 on the PHQ-9
- Ability to read and speak English
- Able to provide written informed consent form
You may not be eligible for this study if the following are true:
-
- Meeting ICHD-3 criteria for persistent headache attributed to traumatic injury to the head (post-traumatic headache) on the Structure Diagnostic Interview for Headache
- Changes in preventive migraine medication or anti-depressant medication within 6 weeks of intake; changes in longer-term migraine prevention (onobotulinum toxin A, anti-calcitonin gene related peptide treatment) within 3 months of intake
- Comorbid psychiatric illness or clinical features that would interfere with participant’s ability to participate in or receive benefit from the MBCT-T intervention, including but not limited to: active suicidal ideation; recent history of psychosis or mania; borderline, histrionic or narcissistic personality disorder; cognitive impairment; sensory disabilities; bipolar disorder; obsessive-compulsive disorder
- Prior history of engaging in formal mindfulness-based interventions including: MBSR, MBCT, Acceptance and Commitment therapy, Dialectical Behavior Therapy
- Current meditation practice >3x/week
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.